Semiconductor Materials and Equipment

inTest

inTest released FY2026 Q1 earnings on May 5 Pre-Market (EST), actual revenue USD 33.89 M (forecast USD 31.69 M), actual EPS USD 0.06 (forecast USD 0.04)

inTest to Release FY2026 Q1 Earnings on May 5, Pre-Market EST; Forecast Revenue USD 31.69 M, EPS USD 0.04

inTest released FY2025 annual earnings on February 27 Pre-Market EST, actual revenue USD 113.83 M (forecast USD 112.23 M), actual EPS USD -0.21 (forecast USD -0.255)

inTest released FY2025 Q4 earnings on February 27 Pre-Market EST, actual revenue USD 32.82 M (forecast USD 31.23 M), actual EPS USD 0.0993 (forecast USD 0.055)

inTest to Release FY2025 Q4 Earnings on February 27, Pre-Market EST; Forecast Revenue USD 31.35 M, EPS USD 0.055

inTest Corporation Secures $3.7 Million Order from Medical Device Maker

inTest Corporation Unveils Growth Strategy

inTest released FY2025 9 Months earnings on November 5 Pre-Market EST, actual revenue USD 81 M, actual EPS USD -0.3124

inTest released FY2025 Q3 earnings on November 5 Pre-Market EST: Actual Revenue USD 26.24 M (Forecast USD 29.11 M), Actual EPS USD -0.08 (Forecast USD -0.0233)

inTest to Release FY2025 Q3 Earnings on November 5 Pre-Market EST, Forecast Revenue USD 29.11 M, EPS USD -0.0233

inTest released FY2025 Q2 earnings on August 6 Pre-Market (EST), actual revenue USD 28.13 M (forecast USD 28 M), actual EPS USD -0.0411 (forecast USD -0.1)

inTest released FY2025 Semi-Annual earnings on August 6 Pre-Market (EST), actual revenue USD 54.77 M, actual EPS USD -0.2321

InTest Secures $2.6 Million Defense Contract

inTest to Release FY2025 Q2 Earnings on August 6, Pre-Market EST; Forecast Revenue USD 28 M, EPS USD -0.1

inTest Corporation Discusses Strategic Growth and Financial Performance at Northern Growth Conference

InTest Corporation Holds Annual General Meeting to Confirm Multiple Proposals

inTest Corp Announces Leadership Changes in Environmental Technology Department

inTEST Corporation Director Buys Shares

Northland lowers Q2 EPS forecast for INTT to negative

inTest Director Gerald J. Maginnis Acquires Common Stock

OPTIMI HEALTH CORP

HCW Biologics

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

Micware

GCL Global

Silexion Therapeutics

MetaVia

MicroAlgo

Vida Global

EMMIS ACQUISITION CORP. ORD USD0.0001 (S/R 12/09/2030)

INTT

InTest (INTT) reported Q1 earnings of $33.89 million in sales and $0.789 million in net income, raising its revenue guidance for the year. Despite a strong stock performance, analysts consider the stock about 7% overvalued with a fair value of $17.67 per share. The company is diversifying into various markets, enhancing revenue resilience. Investors are advised to weigh the potential upside against valuation risks and consider broader investment opportunities.

Simplywall

A Look At InTest (INTT) Valuation After Earnings Beat And Raised Revenue Guidance

InTest Corporation to Present at Upcoming Investor Conferences | INTT Stock News

StockTitan

InTest Corporation to Present at Upcoming Investor Conferences | INTT Stock News

inTest shares are trading lower. The company reported its Q1 financial results.

benzinga_article

Lake Street analyst Frank Takkinen has maintained a Buy rating on inTEST (INTT) with a price target of $19.00. Takkinen, who has an average return of -0.6% and a 38.90% success rate, focuses on the Healthcare sector. The analyst consensus for inTEST is a Moderate Buy, with a price target consensus of $16.50.

Tip Ranks

Daxor

Stereotaxis

CVRx

Lake Street Keeps Their Buy Rating on inTEST (INTT)

InTest Reports Strong First Quarter 2026 Revenue of $33.9 Million, EPS of $0.06 and Adjusted EPS (Non-GAAP) of $0.16 | INTT Stock News

InTest Reports Strong First Quarter 2026 Revenue of $33.9 Million, EPS of $0.06 and Adjusted EPS (Non-GAAP) of $0.16 | INTT Stock News

inTEST has amended its credit agreement with M&T Bank, effective April 30, 2026, through a Seventh Amendment. This amendment extends the term loan draw period to August 28, 2026, and removes inTEST Silicon Valley Corporation as a guarantor. The changes aim to enhance borrowing flexibility and align the guarantor group with the company's structure. The original SEC filing is referenced as INTEST CORP [ INTT ] - 8-K - May. 05, 2026.

inTest(INTT.US)

A Look At InTest (INTT) Valuation After Earnings Beat And Raised Revenue Guidance

InTest Corporation to Present at Upcoming Investor Conferences | INTT Stock News

inTest shares are trading lower. The company reported its Q1 financial results.

Lake Street Keeps Their Buy Rating on inTEST (INTT)

InTest Reports Strong First Quarter 2026 Revenue of $33.9 Million, EPS of $0.06 and Adjusted EPS (Non-GAAP) of $0.16 | INTT Stock News

inTEST Extends Term Loan Draw Period to Aug 28, 2026 in M&T Credit Amendment

inTest | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 33.89 M